Mydriacyl™ (tropicamide ophthalmic solution, USP) Rx Only

Manufacturer
Alcon Laboratories, Inc. | Alcon Research, LLC
Effective date
2023-02-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
9
Source
full-release
Hydrated at
2026-05-31 20:47:17

Label at a glance#

ProductMydriacyl
Active ingredientTROPICAMIDE
Label structure11 sections

Indications and uses

For mydriasis and cycloplegia for diagnostic procedures.

Dosage and administration

For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 or 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

MYDRIACYL™ (tropicamide ophthalmic solution, USP) is an anticholinergic prepared as a sterile topical ophthalmic solution in two strengths. The active ingredient is represented by the chemical structure:

chemical
chemical

Each mL of MYDRIACYL™ (tropicamide ophthalmic solution, USP) contains: Active: tropicamide 1%.
Preservative: benzalkonium chloride 0.01%. Inactives: sodium chloride, edetate disodium, hydrochloric acid and/or sodium hydroxide (to adjust pH), purified water. pH range 4.0 - 5.8.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

This anticholinergic preparation blocks the responses of the sphincter muscle of the iris and the ciliary muscle to cholinergic stimulation, dilating the pupil (mydriasis). The stronger preparation (1%) also paralyzes accommodation. This preparation acts in 15-30 minutes, and the duration of activity is approximately 3-8 hours. Complete recovery from mydriasis in some individuals may require 24 hours. The weaker strength may be useful in producing mydriasis with only slight cycloplegia. Heavily pigmented irides may require more doses than lightly pigmented irides.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

For mydriasis and cycloplegia for diagnostic procedures.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Contraindicated in persons showing hypersensitivity to any component of this preparation.

WARNINGS

WARNINGS SECTION

FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION.

This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered.

Mydriatics may produce a transient elevation of intraocular pressure.

Remove contact lenses before using.

PRECAUTIONS

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to reduce excessive systemic absorption.

Information for Patients

INFORMATION FOR PATIENTS SECTION

Do not touch dropper tip to any surface, as this may contaminate the solution. Patient should be advised not to drive or engage in potentially hazardous activities while pupils are dilated. Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child's mouth and to wash their own hands and the child's hands following administration.

Drug Interactions

DRUG INTERACTIONS SECTION

Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

There have been no long-term studies done using tropicamide in animals to evaluate carcinogenic potential.

Pregnancy

PREGNANCY SECTION

Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tropicamide is administered to a nursing woman.

Pediatric Use

PEDIATRIC USE SECTION

Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs (See WARNINGS). Keep this and all medications out of the reach of children.

Geriatric Use

GERIATRIC USE SECTION

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Ocular: Transient stinging, blurred vision, photophobia and superficial punctuate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydriatics.

Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. For examination of fundus, instill one or two drops of 0.5% solution 15 or 20 minutes prior to examination. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours. However, in some cases, complete recovery may take up to 24 hours.

HOW SUPPLIED

HOW SUPPLIED SECTION

3 mL and 15 mL in plastic DROP-TAINER® dispensers.

1%         3 mL: NDC 0065-0355-03

            15 mL: NDC 0998-0355-15

STORAGE: Store at 8° to 27°C (46° to 80°F). Do not refrigerate or store at high temperatures. Keep container tightly closed.

SPL UNCLASSIFIED SECTION

© 2021 Alcon Inc.
Distributed by:
ALCON LABORATORIES, INC.
Fort Worth, Texas 76134
T2018-39

Revised: November 2021

W300051445-1121                                  Alcon

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0998-0355-15

Alcon®

Mydriacyl® 1%
(tropicamide ophthalmic solution, USP)

15 mL Sterile

Rx Only

A Sterile Anticholinergic Agent.

USUAL DOSAGE: One or two drops topically in the eye(s). Read enclosed insert.

PRECAUTION: Do not touch dropper tip to any surface, as this may contaminate the solution.

INGREDIENTS: Each mL Contains:
Active: tropicamide 1%.
Preservative: benzalkonium chloride 0.01%.
Inactives: sodium chloride, edetate disodium, hydrochloric acid and/or sodium hydroxide (to adjust pH), purified water. pH range 4.0-5.8.

©2002, 2010 Alcon, Inc.

Alcon®
ALCON LABORATORIES, INC.
Fort Worth, Texas. 76134 USA
Product of Japan
9016373 US

STORAGE: Store at 8º-27ºC (46º-80ºF). Do not refrigerate or store at high temperatures. Keep container tightly closed.

FOR TOPICAL OPHTHALMIC USE ONLY.

SN:
LOT:
EXP.:
GTIN: 00309980355156

Carton Label
Carton Label

NDC 0998-0355-15
Alcon®
Mydriacyl® 1%
(tropicamide ophthalmic solution, USP)

Sterile 15 mL

Rx Only         FOR TOPICAL OPHTHALMIC USE ONLY
A Sterile Anticholinergic Agent.
INGREDIENTS: Each mL Contains:
Active: tropicamide 1%. Preservative: benzalkonium
chloride 0.01%. Inactives: sodium chloride, edetate
disodium, hydrochloric acid and/or sodium hydroxide
(to adjust pH), purified water. pH range 4.0-5.8.
USUAL DOSAGE: One or two drops topically
in the eye(s). Read enclosed insert.
PRECAUTION: Do not touch dropper tip to any surface,
as this may contaminate the solution.
STORAGE: Store at 8º-27ºC (46º-80ºF).
Do not refrigerate or store at high temperatures.
Keep container tightly closed.
ALCON LABORATORIES, INC.
Fort Worth, Texas. 76134 USA            Printed in USA
©2002, 2004 Alcon Laboratories, Inc.

H15341 US

LOT:                  EXP.:

Label
Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
208660Mydriacyl 1 % Ophthalmic SolutionPSN9
314238tropicamide 1 % Ophthalmic SolutionPSN9
208660tropicamide 10 MG/ML Ophthalmic Solution [Mydriacyl]SBD9
314238tropicamide 10 MG/ML Ophthalmic SolutionSCD9
208660Mydriacyl 1 % Ophthalmic SolutionSY9
208660Mydriacyl 10 MG/ML Ophthalmic SolutionSY9
314238tropicamide 1 % Ophthalmic SolutionSY9

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
TROPICAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
0f7ae452-206d-4fc4-868d-56fc47074084Product name120231011
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e36a95f-fcff-e2d1-3f9b-17d0b7f9e28cProduct name220200603
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
41722ce4-2429-80d8-5977-d735f8eca6d6Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0998-0355-15Mydriacyl15 mL in 1 BOTTLESOLUTION/ DROPS159
0998-0355-15Mydriacyl1 in 1 CARTONSOLUTION/ DROPS19

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0998-0355MYDRIACYL (TROPICAMIDE) SOLUTION/ DROPS [ALCON LABORATORIES, INC.]9Current NDC, Legacy NDC, 2 package rows20230217_0d4f4a2e-eb00-4c65-b3fa-baf5738d468d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0998-0355-15ML - Milliliter0998-03558165cf5c-6b49-43ff-8d41-63bcdccf95f012012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TROPICAMIDEACTIVE INGREDIENTN0A3Z5XTC61
TROPICAMIDEACTIVE MOIETYN0A3Z5XTC61
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W71
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K1
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0998-03550998-0355-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 10 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii+route+dosage form
2 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION/ DROPS / OPHTHALMIC55 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A084306-001MYDRIACYLTROPICAMIDE1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A084306-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A084306-001MYDRIACYL1%SOLUTION/DROPS / OPHTHALMICATRLD, RS, Approved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A084306-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A084306-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A084306-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A084306-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A084306-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A084306-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A084306-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A084306-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A084306-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A084306-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A084306-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A084306-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A084306-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A084306-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A084306-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A084306-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A084306-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A084306-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A084306-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A084306-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A084306-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A084306-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A084306-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A084306-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A084306-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A084306-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A084306-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A084306-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A084306-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A084306-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A084306-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A084306-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A084306-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A084306-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A084306-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A084306-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A084306-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A084306-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A084306-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A084306-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MydriacylTROPICAMIDEAlcon Laboratories, Inc.0d4f4a2e-eb00-4c65-b3fa-baf5738d468d2023-02-15Warnings, Adverse reactionsExact identifier
ndc (package): 0998-0355-15
ndc (product): 0998-0355
ndc11 (package): 00998035515
spl id: 86af6085-d52b-4516-8234-64ae8baa98b4
spl set id: 0d4f4a2e-eb00-4c65-b3fa-baf5738d468d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.